drugset / Trial / NCT00633360

The Oral Contraceptive Pill for Premenstrual Worsening of Depression

NCT00633360 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

To determine if augmentation with the oral-contraceptive pill containing drospirenone and ethinyl estradiol is more effective than placebo in the treatment of premenstrual breakthrough of depression.

Timeline

Start
2008-02
Primary completion
2011-05
Completion
2011-05

Outcome

Missed primary endpoint

registry Drospirenone and Ethinyl Estradiol vs Placebo; p = .59; Wilcoxon (Mann-Whitney) NCT00633360 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject drospirenone Unknown — Oral
Subject ethinyl estradiol Small molecule — Oral